当前位置: 首页 >> 检索结果
共有 7458 条符合本次的查询结果, 用时 2.6267987 秒

2521. A call for education against hatred.

作者: John Launer.;Sabena Y Jameel.
来源: Lancet. 2024年403卷10445期2684-2685页

2522. Offline: Why have we forgotten about poverty?

作者: Richard Horton.
来源: Lancet. 2024年403卷10445期2678页

2523. Lung cancer treatment: 20 years of progress.

作者: The Lancet.
来源: Lancet. 2024年403卷10445期2663页

2524. Effectiveness and cost-effectiveness of an individualised, progressive walking and education intervention for the prevention of low back pain recurrence in Australia (WalkBack): a randomised controlled trial.

作者: Natasha C Pocovi.;Chung-Wei Christine Lin.;Simon D French.;Petra L Graham.;Johanna M van Dongen.;Jane Latimer.;Dafna Merom.;Anne Tiedemann.;Christopher G Maher.;Ornella Clavisi.;Shuk Yin Kate Tong.;Mark J Hancock.
来源: Lancet. 2024年404卷10448期134-144页
Recurrence of low back pain is common and a substantial contributor to the disease and economic burden of low back pain. Exercise is recommended to prevent recurrence, but the effectiveness and cost-effectiveness of an accessible and low-cost intervention, such as walking, is yet to be established. We aimed to investigate the clinical effectiveness and cost-effectiveness of an individualised, progressive walking and education intervention to prevent the recurrence of low back pain.

2525. Physical activity to prevent recurrences of low back pain.

作者: Diarmuid Denneny.;Jackie Walumbe.
来源: Lancet. 2024年404卷10448期98-100页

2526. Political courage needed to prevent the next pandemic.

作者: Helen Clark.;Mauricio Cárdenas.;Mark Dybul.;Michel Kazatchkine.;Joanne Liu.;Henry E Mark.;Rosemary McCarney.;Christine McNab.;David Miliband.;Anders Nordström.;Thoraya Ahmed Obaid.;Raj Panjabi.;Elizabeth Radin.;George Werner.;Ellen Johnson Sirleaf.
来源: Lancet. 2024年404卷10447期8-11页

2527. The updated International Health Regulations: good news for global health equity.

作者: Ashley Bloomfield.;Abdullah Assiri.
来源: Lancet. 2024年403卷10446期2761-2762页

2528. Peptic ulcer disease.

作者: Majid A Almadi.;Yidan Lu.;Ali A Alali.;Alan N Barkun.
来源: Lancet. 2024年404卷10447期68-81页
Annual prevalence estimates of peptic ulcer disease range between 0·12% and 1·5%. Peptic ulcer disease is usually attributable to Helicobacter pylori infection, intake of some medications (such as aspirin and non-steroidal anti-inflammatory medications), or being critically ill (stress-related), or it can be idiopathic. The clinical presentation is usually uncomplicated, with peptic ulcer disease management based on eradicating H pylori if present, the use of acid-suppressing medications-most often proton pump inhibitors (PPIs)-or addressing complications, such as with early endoscopy and high-dose PPIs for peptic ulcer bleeding. Special considerations apply to patients on antiplatelet and antithrombotic agents. H pylori treatment has evolved, with the choice of regimen dictated by local antibiotic resistance patterns. Indications for primary and secondary prophylaxis vary across societies; most suggest PPIs for patients at highest risk of developing a peptic ulcer, its complications, or its recurrence. Additional research areas include the use of potassium-competitive acid blockers and H pylori vaccination; the optimal approach for patients at risk of stress ulcer bleeding requires more robust determinations of optimal patient selection and treatment selection, if any. Appropriate continuation of PPI use outweighs most possible side-effects if given for approved indications, while de-prescribing should be trialled when a definitive indication is no longer present.

2530. Protecting the blood donor: ferritin-based intervals to improve donor health.

作者: Laura Infanti.
来源: Lancet. 2024年404卷10447期2-3页

2531. Effectiveness of ferritin-guided donation intervals in whole-blood donors in the Netherlands (FIND'EM): a stepped-wedge cluster-randomised trial.

作者: Amber Meulenbeld.;Steven Ramondt.;Maike G Sweegers.;Franke A Quee.;Femmeke J Prinsze.;Emiel O Hoogendijk.;Dorine W Swinkels.;Katja van den Hurk.
来源: Lancet. 2024年404卷10447期31-43页
Whole-blood donors are at increased risk for iron deficiency and anaemia. The current standard of haemoglobin monitoring is insufficient to ensure the maintenance of proper iron reserves and donor health. We aimed to determine the effects of ferritin-guided donation intervals for blood donor health and blood supply in the Netherlands.

2532. A programme for greater health equity for the next UK Government.

作者: Michael Marmot.;Jessica Allen.
来源: Lancet. 2024年403卷10445期2675-2677页

2533. Ulcers, stress, and the discovery of Helicobacter pylori.

作者: Christopher Crenner.
来源: Lancet. 2024年403卷10444期2586-2587页

2534. Mental health in emergencies requires "a major rethink".

作者: John Zarocostas.
来源: Lancet. 2024年403卷10444期2582页

2535. Israel border closure denying health care to Gazans.

作者: Saleyha Ahsan.
来源: Lancet. 2024年403卷10444期2581页

2536. African vaccine manufacturing scheme to boost production.

作者: Udani Samarasekera.
来源: Lancet. 2024年403卷10444期2579-2580页

2537. Persistent physical symptoms: definition, genesis, and management.

作者: Bernd Löwe.;Anne Toussaint.;Judith G M Rosmalen.;Wei-Lieh Huang.;Christopher Burton.;Angelika Weigel.;James L Levenson.;Peter Henningsen.
来源: Lancet. 2024年403卷10444期2649-2662页
Persistent physical symptoms (synonymous with persistent somatic symptoms) is an umbrella term for distressing somatic complaints that last several months or more, regardless of their cause. These symptoms are associated with substantial disability and represent a major burden for patients, health-care professionals, and society. Persistent physical symptoms can follow infections, injuries, medical diseases, stressful life events, or arise de novo. As symptoms persist, their link to clearly identifiable pathophysiology often weakens, making diagnosis and treatment challenging. Multiple biological and psychosocial risk factors and mechanisms contribute to the persistence of somatic symptoms, including persistent inflammation; epigenetic profiles; immune, metabolic and microbiome dysregulation; early adverse life experiences; depression; illness-related anxiety; dysfunctional symptom expectations; symptom focusing; symptom learning; and avoidance behaviours, with many factors being common across symptoms and diagnoses. Basic care consists of addressing underlying pathophysiology and using person-centred communication techniques with validation, appropriate reassurance, and biopsychosocial explanation. If basic care is insufficient, targeted psychological and pharmacological interventions can be beneficial. A better understanding of the multifactorial persistence of somatic symptoms should lead to more specific, personalised, and mechanism-based treatment, and a reduction in the stigma patients commonly face.

2538. Time-lagged amelioration of vascular endothelial function in malignant hypertension: different organs improved at different rates.

作者: Shin-Ichiro Hayashi.;Yuhei Kawano.;Ryuichi Morishita.;Kengo F Kusano.
来源: Lancet. 2024年403卷10444期2630-2631页

2539. Effectiveness of a symptom-clinic intervention delivered by general practitioners with an extended role for people with multiple and persistent physical symptoms in England: the Multiple Symptoms Study 3 pragmatic, multicentre, parallel-group, individually randomised controlled trial.

作者: Christopher Burton.;Cara Mooney.;Laura Sutton.;David White.;Jeremy Dawson.;Aileen R Neilson.;Gillian Rowlands.;Steve Thomas.;Michelle Horspool.;Kate Fryer.;Monica Greco.;Tom Sanders.;Ruth E Thomas.;Cindy Cooper.;Emily Turton.;Waquas Waheed.;Jonathan Woodward.;Ellen Mallender.;Vincent Deary.
来源: Lancet. 2024年403卷10444期2619-2629页
People with multiple and persistent physical symptoms have impaired quality of life and poor experiences of health care. We aimed to evaluate the effectiveness of a community-based symptom-clinic intervention in people with multiple and persistent physical symptoms, hypothesising that this symptoms clinic plus usual care would be superior to usual care only.
共有 7458 条符合本次的查询结果, 用时 2.6267987 秒